The Oncology Institute, Inc.TOIIWNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+27.9%
5Y CAGR+22.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+27.9%/yr
Annual compound
5Y CAGR
+22.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $339.42M | +28.2% |
| 2023 | $264.67M | +32.1% |
| 2022 | $200.39M | +23.6% |
| 2021 | $162.16M | +7.6% |
| 2020 | $150.64M | +20.1% |
| 2019 | $125.46M | +44.4% |
| 2018 | $86.88M | - |